Which prosthesis is more resistant to vascular graft infection: polytetrafluoroethylene or Omniflow II biosynthetic grafts?

Surgery Today ◽  
2015 ◽  
Vol 46 (3) ◽  
pp. 363-370 ◽  
Author(s):  
Orhan Bozoglan ◽  
Bulent Mese ◽  
Erdinc Eroglu ◽  
Serdal Elveren ◽  
Mustafa Gul ◽  
...  
Vascular ◽  
2020 ◽  
pp. 170853812097415
Author(s):  
Hozan Mufty ◽  
Sabrina Houthoofd ◽  
Kim Daenens ◽  
Inge Fourneau

Introduction Omniflow II is promoted as an infection-resistant vascular graft. It is used to treat vascular graft infection; nevertheless, early graft infection has been reported. Report: A 71-year-old patient was treated with an Omniflow II bypass for a non-healing diabetic foot ulcer. Seven months postoperatively, late infection occurred secondary to hematogenous spread from a persistent foot infection. Conclusion We report on the first case of late infection of an Omniflow II vascular graft caused by hematogenous spread. Despite promising results of the Omniflow II graft in the treatment of vascular graft infection, late infection may not be avoided.


VASA ◽  
2020 ◽  
Vol 49 (4) ◽  
pp. 281-284
Author(s):  
Atıf Yolgosteren ◽  
Gencehan Kumtepe ◽  
Melda Payaslioglu ◽  
Cuneyt Ozakin

Summary. Background: Prosthetic vascular graft infection (PVGI) is a complication with high mortality. Cyanoacrylate (CA) is an adhesive which has been used in a number of surgical procedures. In this in-vivo study, we aimed to evaluate the relationship between PVGI and CA. Materials and methods: Thirty-two rats were equally divided into four groups. Pouch was formed on back of rats until deep fascia. In group 1, vascular graft with polyethyleneterephthalate (PET) was placed into pouch. In group 2, MRSA strain with a density of 1 ml 0.5 MacFarland was injected into pouch. In group 3, 1 cm 2 vascular graft with PET piece was placed into pouch and MRSA strain with a density of 1 ml 0.5 MacFarland was injected. In group 4, 1 cm 2 vascular graft with PET piece impregnated with N-butyl cyanoacrylate-based adhesive was placed and MRSA strain with a density of 1 ml 0.5 MacFarland was injected. All rats were scarified in 96th hour, culture samples were taken where intervention was performed and were evaluated microbiologically. Bacteria reproducing in each group were numerically evaluated based on colony-forming unit (CFU/ml) and compared by taking their average. Results: MRSA reproduction of 0 CFU/ml in group 1, of 1410 CFU/ml in group 2, of 180 200 CFU/ml in group 3 and of 625 300 CFU/ml in group 4 was present. A statistically significant difference was present between group 1 and group 4 (p < 0.01), between group 2 and group 4 (p < 0.01), between group 3 and group 4 (p < 0.05). In terms of reproduction, no statistically significant difference was found in group 1, group 2, group 3 in themselves. Conclusions: We observed that the rate of infection increased in the cyanoacyrylate group where cyanoacrylate was used. We think that surgeon should be more careful in using CA in vascular surgery.


2007 ◽  
Vol 33 (5) ◽  
pp. 610-613 ◽  
Author(s):  
M. Mirzaie ◽  
J.D. Schmitto ◽  
T. Tirilomis ◽  
S. Fatehpur ◽  
O.J. Liakopoulos ◽  
...  

2007 ◽  
Vol 28 (4) ◽  
pp. 297-300 ◽  
Author(s):  
Gene G. Tronco ◽  
Charito Love ◽  
Josephine N. Rini ◽  
Alice K. Yu ◽  
Kuldeep K. Bhargava ◽  
...  

1984 ◽  
Vol 1 (1) ◽  
pp. 36-44 ◽  
Author(s):  
Linda M. Reilly ◽  
Howard Altman ◽  
Robert J. Lusby ◽  
Robert A. Kersh ◽  
William K. Ehrenfeld ◽  
...  

Author(s):  
Hazem El Beyrouti ◽  
Mohammad Bashar Izzat ◽  
Angela Kornberger ◽  
Nancy Halloum ◽  
Kathrin Dohle ◽  
...  

Abstract Background Prosthetic vascular grafts placed surgically or via endovascular techniques can be subject to the risk of life-threatening graft infections. The Omniflow II vascular prosthesis is a biosynthetic graft that was reported to have favorable properties in resisting infections. Materials and Methods We retrospectively reviewed our 3 years' experience of using the Omniflow II prostheses for aortoiliac reconstructions in patients considered to carry a substantial risk of subsequent prosthetic graft infections (prevention group) as well as in patients with actively infected prosthetic vascular grafts (treatment group). Results Aorto-bi-iliac (n = 4) and aortobifemoral (n = 12) vascular reconstructions were performed using bifurcated Omniflow II prostheses in nine patients in the prevention group and seven patients in the treatment group. During mean follow-up of 28.6 ± 17.2 months, there was one case of graft infection (6.3%) and graft thrombosis (6.3%) with subsequent successful thrombectomy. Early and late surgical revisions were required in eight (50%) and two (12.6%) patients, respectively. All graft prostheses were patent at last follow-up. Conclusion Using bifurcated Omniflow II vascular prostheses in patients with or at a high risk of vascular graft infection is advisable, and is associated with acceptable reinfection and patency rates.


2014 ◽  
Vol 3 (2) ◽  
pp. 215-223 ◽  
Author(s):  
Laurence Legout ◽  
Piervito D’Elia ◽  
Beatrice Sarraz-Bournet ◽  
Nicolas Ettahar ◽  
Stephan Haulon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document